Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

Market sentiment signals for Cue Biopharma (CUE): analyst consensus, short interest, options flow and insider activity.
Analyst Consensus
Buy
8 analysts
Options Flow (P/C)
—
Avg Consensus PT
$119
+3432.0%
Highest Price Target
$300
+8775.7%
Lowest Price Target
$25
+639.6%
Short Interest
12.5%
Rising — Bearish
Insider Activity (30d)
—
Short Interest — % of Float
| Date | Firm | Analyst & Accuracy | Upside / Downside | PT Change | Action | Rating |
|---|---|---|---|---|---|---|
| Nov 18, 2026 | B. Riley Securities | Mayank Mamtani— | +639.6% | $83 → $25 | Maintained | Buy |
| Sep 18, 2026 | B. Riley Securities | Mayank Mamtani— | +2355.6% | $83 | Initiate | Buy |